A January 2026 The Ophthalmologist article outlines how personalised CXL is applied in three real-world scenarios: good vision, cataract planning, and markedly irregular corneas.
Emilio Torres-Netto reviewed the evolution of epi-on CXL at KCXL 2025, explaining early failures and how modern protocols now achieve clinically meaningful keratoconus stabilisation.
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
ELZA Institute’s Dr. Torres-Netto presents advances in surgical keratoconus treatment and ELZA-PACE-CXL at AAO 2025.
Auf dem ESCRS 2025 in Kopenhagen präsentierte Dr. Emilio A. Torres-Netto neue Strategien zur Behandlung von Patienten mit Katarakt und Keratokonus – einer besonders anspruchsvollen Kombination.
The ELZA team presented at OPT-X.25 in Baden, showcasing our Zurich keratoconus treatment expertise from diagnostics and contact lenses to advanced surgical care
The K-MAP study reports keratoconus prevalence of 0.5% in Ufa, Russia, ten times higher than past estimates, Emlio Torres-Netto tells OSN.
Highlights from ESCRS 2025 ELZA Institute Sunday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
Highlights from ESCRS 2025 ELZA Institute Sunday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
Highlights from ESCRS 2025 ELZA Institute Friday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
